← Evidence map

ArticleTherapeutic advances in medical oncology2018

Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients.

Niki Karachaliou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

180 papers cite itlatest 60 shown

2018
…
2019
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29383037